NewAmsterdam Pharma
4 known investors
NewAmsterdam Pharma develops innovative therapies for cardiovascular disease and lipid-related conditions. The company aims to provide lipid-lowering treatments that help patients with cardiovascular risk manage their health.
BiotechHealthtechMedical Devices
Investors · 4
Competitors · 3
by search overlapSeeking Alpha27 shared keywordsSeeking Alpha is a financial research platform that provides stock analysis, investment tools, and market coverage across asset classes to investors. The platform aggregates research from thousands of analysts and investors, offering ratings, articles, and investment ideas.
Robinhood23 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Simply Wall St21 shared keywordsSimply Wall St is a stock analysis platform that provides portfolio insights, stock discovery tools, and market alerts for individual investors. The service offers institutional-grade financial data visualization and analysis across 120,000 global stocks.
Companies competing with NewAmsterdam Pharma for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does NewAmsterdam Pharma do?
- NewAmsterdam Pharma develops innovative therapies for cardiovascular disease and lipid-related conditions. The company aims to provide lipid-lowering treatments that help patients with cardiovascular risk manage their health.
- Who are NewAmsterdam Pharma's investors?
- NewAmsterdam Pharma's investors include Bain Capital Life Sciences, EQT Life Sciences, Frazier Life Sciences, LSP (Life Sciences Partners).